Potentially there is, Ms. Wagantall. We're very interested in doing some research in this area.
We have an investigation under way through our Repatriation Medical Authority, the statutory body that sets the rules under which compensation claims are determined. They're doing a literature review, basically, and presently looking at and checking the current evidence for whether there is a need to have statements of principles in respect of chemically acquired brain injury caused by mefloquine or the related drugs. That report is due to come out within the next couple of months.
In light of whatever evidence is revealed in that investigation, we propose to develop a research proposal jointly with the Department of Defence, and we'd be absolutely open to an international collaboration on that. In fact, we have had conversations about our mutual research interests with our colleagues in the Canadian Veterans Affairs department on a regular basis anyway, so we're very happy to add that to the list of things that we would consider.